Teleflex Incorporated
Teleflex Incorporated (TFX) Covered Calls
As of September 21, 2026, TFX has 25 covered call opportunities in the coming three months. Return ranges from 2.8 to 36.7% until expiration. Annualized return ranges from 17.8 to 110.8%. The nearest expiration is October 16, 2026. Maximum potential profit is $4,568.
Read more
Running TFX covered calls helps you generate consistent income from Teleflex Incorporated's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Teleflex Incorporated involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best TFX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if TFX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling TFX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Teleflex Incorporated covered call is worth writing.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Income-focused investors, long-term TFX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling TFX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Teleflex Incorporated covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV percentile73.81% Elevated
- Market cap (M$)5,288
- 52 weeks high-13.93%
- 52 weeks low24.58%
- Analyst recommendationBuy
2.44 - Target price$153.55
23.06% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E11.40
- EPS (ttm)-23.29
- EPS growth next 5 years20.16%
As of September 21, 2026
| 2026-10-16 | 28 | 135.00 | 8.42 | 0.10 | 4.90 | 1058.00 | 8.50 | 110.76 | -0.08 | +0.28 | 27 | 4.80 |
| 2026-11-20 | 63 | 145.00 | 16.45 | 0.20 | 4.90 | 2068.00 | 16.61 | 96.22 | -0.16 | +0.22 | 0 | 4.70 |
| 2026-11-20 | 63 | 140.00 | 12.43 | 0.75 | 4.90 | 1623.00 | 13.03 | 75.51 | -0.60 | +0.26 | 0 | 4.15 |
| 2027-01-15 | 119 | 155.00 | 24.48 | 0.10 | 4.90 | 3058.00 | 24.56 | 75.33 | -0.08 | +0.19 | 43 | 4.80 |
| 2026-10-16 | 28 | 130.00 | 4.40 | 1.10 | 5.00 | 658.00 | 5.28 | 68.88 | -0.88 | +0.37 | 1 | 3.90 |
| 2027-04-16 | 210 | 170.00 | 36.52 | 0.20 | 4.90 | 4568.00 | 36.68 | 63.76 | -0.16 | +0.17 | 0 | 4.70 |
| 2027-01-15 | 119 | 150.00 | 20.46 | 0.40 | 4.90 | 2588.00 | 20.78 | 63.75 | -0.32 | +0.21 | 0 | 4.50 |
| 2026-11-20 | 63 | 135.00 | 8.42 | 2.00 | 6.50 | 1248.00 | 10.02 | 58.07 | -1.61 | +0.35 | 0 | 4.50 |
| 2027-04-16 | 210 | 165.00 | 32.51 | 0.50 | 4.90 | 4098.00 | 32.91 | 57.20 | -0.40 | +0.18 | 0 | 4.40 |
| 2027-01-15 | 119 | 145.00 | 16.45 | 1.15 | 6.00 | 2163.00 | 17.37 | 53.28 | -0.92 | +0.27 | 11 | 4.85 |
As of September 21, 2026
Sell covered calls with the data behind you
Find the best TFX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→